FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Cohen

Research Profile

Procedures

Tomography, Emission-Computed

Anatomy

Disorders

Chemicals & Drugs

Concepts & Ideas

Psychiatric Status Rating Scales

Living Beings

Macaca mulatta

Physiology

Co-author Network

Publications

TOP 3
Faramarz Ismail-Beigi; Timothy Craven; Mary Ann Banerji; Jan Basile; Jorge Calles; Robert M Cohen; Robert Cuddihy; William C Cushman; Saul Genuth; Richard H Grimm; Bruce P Hamilton; Byron Hoogwerf; Diane Karl; Lois Katz; Armand Krikorian; Patrick O'Connor; Rodica Pop-Busui; Ulrich Schubart; Debra Simmons; Harris Taylor; Abraham H. Thomas; Daniel Weiss; Irene Hramiak
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.
Francesca Filbey; Kelly J Slack; Trey Sunderland; Robert M Cohen
Functional magnetic resonance imaging and magnetoencephalography differences associated with APOEepsilon4 in young healthy adults.
Robert M Cohen; Joanna Szczepanik; Michael McManus; Nadeem Mirza; Karen Putnam; Jim Levy; Trey Sunderland
Hippocampal atrophy in the healthy is initially linear and independent of age.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Cohen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Faramarz Ismail-Beigi; Timothy Craven; Mary Ann Banerji; Jan Basile; Jorge Calles; Robert M Cohen; Robert Cuddihy; William C Cushman; Saul Genuth; Richard H Grimm; Bruce P Hamilton; Byron Hoogwerf; Diane Karl; Lois Katz; Armand Krikorian; Patrick O'Connor; Rodica Pop-Busui; Ulrich Schubart; Debra Simmons; Harris Taylor; Abraham H. Thomas; Daniel Weiss; Irene Hramiak
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.
Lancet 2010;376(9739):419-30.
2006: Francesca Filbey; Kelly J Slack; Trey Sunderland; Robert M Cohen
Functional magnetic resonance imaging and magnetoencephalography differences associated with APOEepsilon4 in young healthy adults.
Neuroreport 2006;17(15):1585-90.
2006: Robert M Cohen; Joanna Szczepanik; Michael McManus; Nadeem Mirza; Karen Putnam; Jim Levy; Trey Sunderland
Hippocampal atrophy in the healthy is initially linear and independent of age.
Neurobiology of aging 2006;27(10):1385-94.
2006: Trey Sunderland; Harald Hampel; Masatoshi Takeda; Karen Putnam; Robert M Cohen
Biomarkers in the diagnosis of Alzheimer's disease: are we ready?
Journal of geriatric psychiatry and neurology 2006;19(3):172-9.
2006: Robert M Cohen; Richard E Carson; Francesca Filbey; Joanna Szczepanik; Trey Sunderland
Age and APOE-epsilon4 genotype influence the effect of physostigmine infusion on the in-vivo distribution volume of the muscarinic-2-receptor dependent tracer [18F]FP-TZTP.
Synapse (New York, N.Y.) 2006;60(1):86-92.
2006: Edward D Huey; Nadeem Mirza; Karen Putnam; Holly Soares; Gyorgy Csako; James A Levy; Brittany Copenhaver; Robert M Cohen; Trey Sunderland
Stability of CSF beta-amyloid(1-42) and tau levels by APOE genotype in Alzheimer patients.
Dementia and geriatric cognitive disorders 2006;22(1):48-53.
2006: Masahiro Fujita; Masanori Ichise; Sami S Zoghbi; Jeih-San Liow; Subroto Ghose; Douglass C Vines; Janet Sangare; Jian-Qiang Lu; Vanessa L Cropley; Hidehiro Iida; Kyeong Min Kim; Robert M Cohen; William Bara-Jimenez; Bernard Ravina; Robert B Innis
Widespread decrease of nicotinic acetylcholine receptors in Parkinson's disease.
Annals of neurology 2006;59(1):174-7.
2005: Francesca Filbey; Tom Holroyd; Frederick W Carver; Trey Sunderland; Robert M Cohen
A magnetoencephalography spatiotemporal analysis of neural activities during feature binding.
Neuroreport 2005;16(16):1747-52.
2005: Hiroshi Toyama; Daniel Ye; Masanori Ichise; Jeih-San Liow; Lisheng Cai; David Jacobowitz; John L Musachio; Jinsoo Hong; Mathew Crescenzo; Dnyanesh N Tipre; Jian-Qiang Lu; Sami S Zoghbi; Douglass C Vines; Jurgen Seidel; Kazuhiro Katada; Michael V Green; Victor W Pike; Robert M Cohen; Robert B Innis
PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease.
European journal of nuclear medicine and molecular imaging 2005;32(5):593-600.
2005: H Eleanor Cannon-Spoor; James A Levy; George S Zubenko; Wendy W Zubenko; Robert M Cohen; Nadeem Mirza; Karen Putnam; Trey Sunderland
Effects of previous major depressive illness on cognition in Alzheimer disease patients.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2005;13(4):312-8.
2004: Trey Sunderland; Nadeem Mirza; Karen Putnam; Gary Linker; Deepa Bhupali; Rob Durham; Holly Soares; Lida Kimmel; David Friedman; Judy Bergeson; Gyorgy Csako; James A Levy; John J Bartko; Robert M Cohen
Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Biological psychiatry 2004;56(9):670-6.
2003: Robert M Cohen; Teresa A Podruchny; Arun Bokde; Richard E Carson; Peter Herscovitch; Dale O Kiesewetter; William Eckelman; Trey Sunderland
Higher in vivo muscarinic-2 receptor distribution volumes in aging subjects with an apolipoprotein E-epsilon4 allele.
Synapse (New York, N.Y.) 2003;49(3):150-6.
2003: Trey Sunderland; Gary Linker; Nadeem Mirza; Karen Putnam; David L Friedman; Lida H Kimmel; Judy Bergeson; Guy J Manetti; Matthew Zimmermann; Brian Tang; John J Bartko; Robert M Cohen
Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease.
JAMA : the journal of the American Medical Association 2003;289(16):2094-103.
2003: Teresa A Podruchny; Catherine Connolly; Arun Bokde; Peter Herscovitch; William Eckelman; Dale O Kiesewetter; Trey Sunderland; Richard E Carson; Robert M Cohen
In vivo muscarinic 2 receptor imaging in cognitively normal young and older volunteers.
Synapse (New York, N.Y.) 2003;48(1):39-44.
2000: Robert M Cohen; Richard E Carson; Trey Sunderland
Opiate receptor avidity in the thalamus is sexually dimorphic in the elderly.
Synapse (New York, N.Y.) 2000;38(2):226-9.
2000: Robert M Cohen; Richard E Carson; Richard C Saunders; Doris J Doudet
Opiate receptor avidity is increased in rhesus monkeys following unilateral optic tract lesion combined with transections of corpus callosum and hippocampal and anterior commissures.
Brain research 2000;879(1-2):1-6.
2000: Monique Ernst; Alan J Zametkin; DM Pascualvaca; John A Matochik; Graeme Eisenhofer; Dennis L Murphy; Robert M Cohen
Adrenergic and noradrenergic plasma levels in Lesch-Nyhan disease.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;22(3):320-6.
1999: Robert M Cohen; thomas nordahl; WE Semple; DAVID PICKAR
The brain metabolic patterns of clozapine- and fluphenazine-treated female patients with schizophrenia: evidence of a sex effect.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;21(5):632-40.
1999: Robert M Cohen; Richard E Carson; R J Wyatt; Doris J Doudet
Opiate receptor avidity is reduced bilaterally in rhesus monkeys unilaterally lesioned with MPTP.
Synapse (New York, N.Y.) 1999;33(4):282-8.
1999: Monique Ernst; Alan J Zametkin; John A Matochik; DM Pascualvaca; PH Jons; Robert M Cohen
High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder.
The American journal of psychiatry 1999;156(8):1209-15.
1999: Monique Ernst; Alan J Zametkin; PH Jons; John A Matochik; DM Pascualvaca; Robert M Cohen
High presynaptic dopaminergic activity in children with Tourette's disorder.
Journal of the American Academy of Child and Adolescent Psychiatry 1999;38(1):86-94.
1998: thomas nordahl; M B Stein; C Benkelfat; WE Semple; PJ Andreason; Alan J Zametkin; Thomas W Uhde; Robert M Cohen
Regional cerebral metabolic asymmetries replicated in an independent group of patients with panic disorders.
Biological psychiatry 1998;44(10):998-1006.
1998: Robert M Cohen; Richard E Carson; T G Aigner; Doris J Doudet
Opiate receptor avidity is reduced in non-motor impaired MPTP-lesioned rhesus monkeys.
Brain research 1998;806(2):292-6.
1998: Monique Ernst; Alan J Zametkin; John A Matochik; PH Jons; Robert M Cohen
DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1998;18(15):5901-7.
1998: Robert M Cohen; thomas nordahl; WE Semple; PJ Andreason; DAVID PICKAR
Abnormalities in the distributed network of sustained attention predict neuroleptic treatment response in schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1998;19(1):36-47.
1998: Monique Ernst; Alan J Zametkin; R L Phillips; Robert M Cohen
Age-related changes in brain glucose metabolism in adults with attention-deficit/hyperactivity disorder and control subjects.
The Journal of neuropsychiatry and clinical neurosciences 1998;10(2):168-77.
1998: Dennis L Murphy; F Karoum; DAVID PICKAR; Robert M Cohen; S Lipper; Alan M Mellow; Pierre N. Tariot; Trey Sunderland
Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline).
Journal of neural transmission. Supplementum 1998;52():39-48.
1997: Monique Ernst; Alan J Zametkin; John A Matochik; M Schmidt; PH Jons; LL Liebenauer; K K Hardy; Robert M Cohen
Intravenous dextroamphetamine and brain glucose metabolism.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1997;17(6):391-401.
1997: Monique Ernst; Robert M Cohen; LL Liebenauer; PH Jons; Alan J Zametkin
Cerebral glucose metabolism in adolescent girls with attention-deficit/hyperactivity disorder.
Journal of the American Academy of Child and Adolescent Psychiatry 1997;36(10):1399-406.
1997: Robert M Cohen; PJ Andreason; Doris J Doudet; Richard E Carson; Trey Sunderland
Opiate receptor avidity and cerebral blood flow in Alzheimer's disease.
Journal of the neurological sciences 1997;148(2):171-80.
1997: Robert M Cohen; thomas nordahl; WE Semple; PJ Andreason; R E Litman; DAVID PICKAR
The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task.
Archives of general psychiatry 1997;54(5):481-6.
1997: Robert M Cohen; PJ Andreason; Trey Sunderland
The ratio of mesial to neocortical temporal lobe blood flow as a predictor of dementia.
Journal of the American Geriatrics Society 1997;45(3):329-33.
1996: Monique Ernst; Alan J Zametkin; John A Matochik; DM Pascualvaca; PH Jons; K Hardy; J G Hankerson; Doris J Doudet; Robert M Cohen
Presynaptic dopaminergic deficits in Lesch-Nyhan disease.
The New England journal of medicine 1996;334(24):1568-72.
1996: John A Matochik; Alan J Zametkin; Robert M Cohen; Peter Hauser; Bruce D Weintraub
Abnormalities in sustained attention and anterior cingulate metabolism in subjects with resistance to thyroid hormone.
Brain research 1996;723(1-2):23-8.
1996: Monique Ernst; L L Liebenauer; PH Jons; D Tebeka; Robert M Cohen; Alan J Zametkin
Selegiline in adults with attention deficit hyperactivity disorder: clinical efficacy and safety.
Psychopharmacology bulletin 1996;32(3):327-34.
1995: Mark E Schmidt; John A Matochik; R C Risinger; JL Schouten; Alan J Zametkin; Robert M Cohen; William Z Potter
Regional brain glucose metabolism after acute alpha 2-blockade by idazoxan.
Clinical pharmacology and therapeutics 1995;57(6):684-95.
1995: John A Matochik; SE Molchan; Alan J Zametkin; D L Warden; Trey Sunderland; Robert M Cohen
Regional cerebral glucose metabolism in autopsy-confirmed Creutzfeldt-Jakob disease.
Acta neurologica Scandinavica 1995;91(2):153-7.
1994: JM Rumsey; PJ Andreason; Alan J Zametkin; A C King; SD Hamburger; T Aquino; A P Hanahan; A Pikus; Robert M Cohen
Right frontotemporal activation by tonal memory in dyslexia, an O15 PET Study.
Biological psychiatry 1994;36(3):171-80.
1994: Trey Sunderland; Robert M Cohen; SE Molchan; Brian A Lawlor; Alan M Mellow; Paul Newhouse; Pierre N. Tariot; E A Mueller; Dennis L Murphy
High-dose selegiline in treatment-resistant older depressive patients.
Archives of general psychiatry 1994;51(8):607-15.
1994: Monique Ernst; L L Liebenauer; A C King; garret fitzgerald; Robert M Cohen; Alan J Zametkin
Reduced brain metabolism in hyperactive girls.
Journal of the American Academy of Child and Adolescent Psychiatry 1994;33(6):858-68.
1994: John A Matochik; L L Liebenauer; A C King; H V Szymanski; Robert M Cohen; Alan J Zametkin
Cerebral glucose metabolism in adults with attention deficit hyperactivity disorder after chronic stimulant treatment.
The American journal of psychiatry 1994;151(5):658-64.
1994: SE Molchan; John A Matochik; Alan J Zametkin; H V Szymanski; M Cantillon; Robert M Cohen; Trey Sunderland
A double FDG/PET study of the effects of scopolamine in older adults.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1994;10(3):191-8.
1994: P F Goyer; PJ Andreason; WE Semple; A H Clayton; A C King; B A Compton-Toth; S Charles Schulz; Robert M Cohen
Positron-emission tomography and personality disorders.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1994;10(1):21-8.
1994: JM Rumsey; Alan J Zametkin; PJ Andreason; A P Hanahan; SD Hamburger; T Aquino; A C King; A Pikus; Robert M Cohen
Normal activation of frontotemporal language cortex in dyslexia, as measured with oxygen 15 positron emission tomography.
Archives of neurology 1994;51(1):27-38.
1994: Monique Ernst; Alan J Zametkin; John A Matochik; L Liebenauer; garret fitzgerald; Robert M Cohen
Effects of intravenous dextroamphetamine on brain metabolism in adults with attention-deficit hyperactivity disorder (ADHD). Preliminary findings.
Psychopharmacology bulletin 1994;30(2):219-25.
1994: Robert M Cohen; M Gross; WE Semple; thomas nordahl; Trey Sunderland
The metabolic brain pattern of young subjects given scopolamine.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1994;100(1):133-43.
1993: John A Matochik; thomas nordahl; M Gross; WE Semple; A C King; Robert M Cohen; Alan J Zametkin
Effects of acute stimulant medication on cerebral metabolism in adults with hyperactivity.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1993;8(4):377-86.
1993: Alan J Zametkin; L L Liebenauer; garret fitzgerald; A C King; D V Minkunas; Peter Herscovitch; E M Yamada; Robert M Cohen
Brain metabolism in teenagers with attention-deficit hyperactivity disorder.
Archives of general psychiatry 1993;50(5):333-40.
1993: Doris J Doudet; R J Wyatt; E Cannon-Spoor; R Suddath; C A McLellan; Robert M Cohen
6-[18F]fluoro-L-dopa and cerebral blood flow in unilaterally MPTP-treated monkeys.
Journal of neural transplantation & plasticity 1993;4(1):27-38.
1992: PJ Andreason; M Altemus; Alan J Zametkin; A C King; J Lucinio; Robert M Cohen
Regional cerebral glucose metabolism in bulimia nervosa.
The American journal of psychiatry 1992;149(11):1506-13.
1992: P F Goyer; P M Schulz; WE Semple; M Gross; thomas nordahl; A C King; Thomas Wehr; Robert M Cohen
Cerebral glucose metabolism in patients with summer seasonal affective disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1992;7(3):233-40.
1992: Doris J Doudet; T G Aigner; C A McLellan; Robert M Cohen
Positron emission tomography with 18F-dopa: interpretation and biological correlates in nonhuman primates.
Psychiatry research 1992;45(3):153-68.
1992: Robert M Cohen; M Gross; thomas nordahl; WE Semple; D A Oren; N Rosenthal
Preliminary data on the metabolic brain pattern of patients with winter seasonal affective disorder.
Archives of general psychiatry 1992;49(7):545-52.
1992: Doris J Doudet; C A McLellan; T G Aigner; R J Wyatt; Robert M Cohen
Delayed L-phenylalanine infusion allows for simultaneous kinetic analysis and improved evaluation of specific-to-nonspecific fluorine-18-dopa uptake in brain.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(7):1383-9.
1992: JM Rumsey; PJ Andreason; Alan J Zametkin; T Aquino; A C King; SD Hamburger; A Pikus; Judy Rapoport; Robert M Cohen
Failure to activate the left temporoparietal cortex in dyslexia. An oxygen 15 positron emission tomographic study.
Archives of neurology 1992;49(5):527-34.
1992: Robert M Cohen; WE Semple; M Gross; A C King; thomas nordahl
Metabolic brain pattern of sustained auditory discrimination.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1992;92(1):165-72.
1991: Doris J Doudet; C A McLellan; R Carson; H R Adams; H Miyake; T G Aigner; R T Finn; Robert M Cohen
Distribution and kinetics of 3-O-methyl-6-[18F]fluoro-L-dopa in the rhesus monkey brain.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1991;11(5):726-34.
1991: Doris J Doudet; C A McLellan; T G Aigner; R Wyatt; H R Adams; H Miyake; R T Finn; Robert M Cohen
Postinjection L-phenylalanine increases basal ganglia contrast in PET scans of 6-18F-DOPA.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(7):1408-13.
1991: Trey Sunderland; Wade H Berrettini; SE Molchan; Brian A Lawlor; R A Martinez; Benedetto Vitiello; Pierre N. Tariot; Robert M Cohen
Reduced cerebrospinal fluid dynorphin A1-8 in Alzheimer's disease.
Biological psychiatry 1991;30(1):81-7.
1991: C Benkelfat; I N Mefford; C F Masters; thomas nordahl; A C King; Robert M Cohen; D L Murphy
Plasma catecholamines and their metabolites in obsessive-compulsive disorder.
Psychiatry research 1991;37(3):321-31.
1991: C A McLellan; Doris J Doudet; T Brücke; T G Aigner; Robert M Cohen
New rapid analysis method demonstrates differences in 6-[18F] fluoro-L-dopa plasma input curves with and without carbidopa and in hemi-MPTP lesioned monkeys.
International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes 1991;42(9):847-54.
1990: Alan J Zametkin; thomas nordahl; M Gross; A C King; WE Semple; JM Rumsey; S Hamburger; Robert M Cohen
Cerebral glucose metabolism in adults with hyperactivity of childhood onset.
The New England journal of medicine 1990;323(20):1361-6.
1990: C Benkelfat; thomas nordahl; WE Semple; A C King; Dennis L Murphy; Robert M Cohen
Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine.
Archives of general psychiatry 1990;47(9):840-8.
1990: thomas nordahl; WE Semple; M Gross; Thomas A Mellman; M B Stein; P Goyer; A C King; Thomas W Uhde; Robert M Cohen
Cerebral glucose metabolic differences in patients with panic disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1990;3(4):261-72.
1990: SE Molchan; Alan M Mellow; Brian A Lawlor; H J Weingartner; Robert M Cohen; M R Cohen; Trey Sunderland
TRH attenuates scopolamine-induced memory impairment in humans.
Psychopharmacology 1990;100(1):84-9.
1989: Robert M Cohen; WE Semple; M Gross; thomas nordahl; A C King; DAVID PICKAR; R M Post
Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1989;2(4):241-54.
1989: J J Chen; S J Huang; R D Finn; K L Kirk; B E Francis; H R Adams; Robert M Cohen; C C Chiueh
Quality control procedure for 6-[18F]fluoro-L-DOPA: a presynaptic PET imaging ligand for brain dopamine neurons.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1989;30(7):1249-56.
1989: thomas nordahl; C Benkelfat; WE Semple; M Gross; A C King; Robert M Cohen
Cerebral glucose metabolic rates in obsessive compulsive disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1989;2(1):23-8.
1989: Doris J Doudet; H Miyake; R T Finn; C A McLellan; T G Aigner; R Q Wan; H R Adams; Robert M Cohen
6-18F-L-dopa imaging of the dopamine neostriatal system in normal and clinically normal MPTP-treated rhesus monkeys.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1989;78(1):69-80.
1989: Trey Sunderland; H Weingartner; Robert M Cohen; Pierre N. Tariot; Paul Newhouse; K E Thompson; Brian A Lawlor; E A Mueller
Low-dose oral lorazepam administration in Alzheimer subjects and age-matched controls.
Psychopharmacology 1989;99(1):129-33.
1989: Alan M Mellow; Trey Sunderland; Robert M Cohen; Brian A Lawlor; J L Hill; Paul Newhouse; M R Cohen; Dennis L Murphy
Acute effects of high-dose thyrotropin releasing hormone infusions in Alzheimer's disease.
Psychopharmacology 1989;98(3):403-7.
1988: C S Aulakh; Robert M Cohen; M M Dauphin; C A McLellan; Dennis L Murphy
Role of serotonergic input in the down-regulation of beta-adrenoceptors following long-term clorgyline treatment.
European journal of pharmacology 1988;156(1):63-70.
1988: Pierre N. Tariot; Robert M Cohen; J A Welkowitz; Trey Sunderland; Paul Newhouse; Dennis L Murphy; H Weingartner
Multiple-dose arecoline infusions in Alzheimer's disease.
Archives of general psychiatry 1988;45(10):901-5.
1988: Trey Sunderland; I S Alterman; D Yount; J L Hill; Pierre N. Tariot; Paul Newhouse; E A Mueller; Alan M Mellow; Robert M Cohen
A new scale for the assessment of depressed mood in demented patients.
The American journal of psychiatry 1988;145(8):955-9.
1988: Owen Wolkowitz; A R Doran; M R Cohen; Robert M Cohen; T N Wise; DAVID PICKAR
Single-dose naloxone acutely reduces eating in obese humans: behavioral and biochemical effects.
Biological psychiatry 1988;24(4):483-7.
1988: W Singhaniyom; Yuan-Feen Tsai; T Brücke; C A McLellan; Robert M Cohen; H F Kung; Chuang C Chiueh
Blockade of in vivo binding of 125I-labeled 3-iodobenzamide (IBZM) to dopamine receptors by D2 antagonist and agonist.
Brain research 1988;453(1-2):393-6.
1988: Pierre N. Tariot; Trey Sunderland; Robert M Cohen; Paul Newhouse; E A Mueller; Dennis L Murphy
Tranylcypromine compared with L-deprenyl in Alzheimer's disease.
Journal of clinical psychopharmacology 1988;8(1):23-7.
1988: T Brücke; Yuan-Feen Tsai; C McLellan; W Singhanyom; H F Kung; Robert M Cohen; Chuang C Chiueh
In vitro binding properties and autoradiographic imaging of 3-iodobenzamide ([125I]-IBZM): a potential imaging ligand for D-2 dopamine receptors in SPECT.
Life sciences 1988;42(21):2097-104.
1988: Robert M Cohen; WE Semple; M Gross; thomas nordahl
From syndrome to illness: delineating the pathophysiology of schizophrenia with PET.
Schizophrenia bulletin 1988;14(2):169-76.
1988: Robert M Cohen; WE Semple; M Gross; thomas nordahl; Henry H Holcomb; M S Dowling; DAVID PICKAR
The effect of neuroleptics on dysfunction in a prefrontal substrate of sustained attention in schizophrenia.
Life sciences 1988;43(14):1141-50.
1987: Trey Sunderland; David Rubinow; Pierre N. Tariot; Robert M Cohen; Paul Newhouse; Alan M Mellow; E A Mueller; Dennis L Murphy
CSF somatostatin in patients with Alzheimer's disease, older depressed patients, and age-matched control subjects.
The American journal of psychiatry 1987;144(10):1313-6.
1987: C S Aulakh; Robert M Cohen; J L Hill; Dennis L Murphy; J Zohar
Long-term imipramine treatment enhances locomotor and food intake suppressant effects of m-chlorophenylpiperazine in rats.
British journal of pharmacology 1987;91(4):747-52.
1987: Robert M Cohen; WE Semple; M Gross; thomas nordahl; L E DeLisi; Henry H Holcomb; A C King; J M Morihisa; DAVID PICKAR
Dysfunction in a prefrontal substrate of sustained attention in schizophrenia.
Life sciences 1987;40(20):2031-9.
1987: Pierre N. Tariot; Robert M Cohen; Trey Sunderland; Paul Newhouse; D Yount; Alan M Mellow; H Weingartner; E A Mueller; Dennis L Murphy
L-deprenyl in Alzheimer's disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibition.
Archives of general psychiatry 1987;44(5):427-33.
1987: Pierre N. Tariot; Trey Sunderland; H Weingartner; Dennis L Murphy; J A Welkowitz; K Thompson; Robert M Cohen
Cognitive effects of L-deprenyl in Alzheimer's disease.
Psychopharmacology 1987;91(4):489-95.
1987: Trey Sunderland; Pierre N. Tariot; Robert M Cohen; Paul Newhouse; Alan M Mellow; E A Mueller; Dennis L Murphy
Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease.
Psychopharmacology 1987;91(3):293-6.
1986: Paul Newhouse; Trey Sunderland; Pierre N. Tariot; E A Mueller; Dennis L Murphy; Robert M Cohen
Prolactin response to TRH in Alzheimer's disease and elderly controls.
Biological psychiatry 1986;21(10):963-7.
1986: Dale O Kiesewetter; William Eckelman; Robert M Cohen; R D Finn; Steven M Larson
Syntheses and D2 receptor affinities of derivatives of spiperone containing aliphatic halogens.
International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes 1986;37(12):1181-8.
1986: Pierre N. Tariot; Trey Sunderland; Dennis L Murphy; M R Cohen; J A Welkowitz; H Weingartner; Paul Newhouse; Robert M Cohen
Design and interpretation of opiate antagonist trials in dementia.
Progress in neuro-psychopharmacology & biological psychiatry 1986;10(3-5):611-26.
1985: Trey Sunderland; Pierre N. Tariot; E A Mueller; Paul Newhouse; Dennis L Murphy; Robert M Cohen
TRH stimulation test in dementia of the Alzheimer type and elderly controls.
Psychiatry research 1985;16(4):269-75.
1985: L E DeLisi; Henry H Holcomb; Robert M Cohen; DAVID PICKAR; William T Carpenter; J M Morihisa; A C King; R Kessler; Monte Buchsbaum
Positron emission tomography in schizophrenic patients with and without neuroleptic medication.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1985;5(2):201-6.
1983: C S Aulakh; Robert M Cohen; C McLellan; Dennis L Murphy
Correlation of changes in alpha 2-adrenoceptor number and locomotor responses to clonidine following clorgyline discontinuation.
British journal of pharmacology 1983;80(1):10-2.